Effect of topical anesthesia and age on pain scores during retinopathy of prematurity screening

Mehta, Manisha; Mansfield, Theresa A.; VanderVeen, Deborah K.

doi:10.1038/jp.2010.36

Cited by 27 publications

(25 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mehta and colleagues 18 compared the response of infants at 2 age points (33.3 and 35.3 weeks) and 2 examination time points (1 and 5 minutes). 18 At the first examination, the PIPP score was significantly lower in the treated group at 1 and 5 minutes, but at the second examination, the PIPP score was lower than at the first examination in both patients and control patients. As a result of the lower overall scores at the second examination, there was no significant difference between treated and control groups.…”

Section: Topical Anesthesiamentioning

confidence: 67%

See 1 more Smart Citation

Pain relief for premature infants during ophthalmology assessment

Kandasamy

Smith

Wright

et al. 2011

Journal of American Association for Pediatric Ophthalmology and

View full text Add to dashboard Cite

Section: Topical Anesthesiamentioning

confidence: 67%

“…Table 1 [16][17][18][19] compares 4 different controlled studies of the effects of topical proparacaine on pain relief in premature infants during ROP examinations. In an earlier study of 42 patients, Saunders and colleagues 16 showed no advantage over saline eye drops; however, that study used no standardized method of pain scoring.…”

Section: Topical Anesthesiamentioning

confidence: 99%

Pain relief for premature infants during ophthalmology assessment

Kandasamy

Smith

Wright

et al. 2011

Journal of American Association for Pediatric Ophthalmology and

View full text Add to dashboard Cite

“…Many studies found a decreased ''Premature Infant Pain Profile'' scores after instillation of topical anesthetic proparacaine 0.5% eye drops and supported the use of it during eye examinations of premature babies, which marginally decreases pain without any adverse effects. 12 The frequency of BP was still high after instillation of topical anesthetic in the current study.…”

Section: A Significant Challenge During Retinopathy Of Prematurity Scmentioning

confidence: 68%

A Significant Challenge During Retinopathy of Prematurity Screening: Bell's Phenomenon

Şekeroğlu¹,

Hekimoğlu²,

Petriçli³

et al. 2015

Turkiye Klinikleri J Ophthalmol

View full text Add to dashboard Cite

A AB BS S T TR RA AC CT T O Ob bj je ec ct ti iv ve e: : To evaluate the expression of Bell's phenomenon (BP) in premature infants and to discuss the effects of BP expression on retinopathy of prematurity screening examination. M Ma at te er ri ia al l a an nd d M Me et th ho od ds s: : Consecutive infants admitted for retinopathy of prematurity screening examination were all recruited. The expression of BP was evaluated just after the insertion of the blepharostat and during illumination of the eye by the binocular indirect ophthalmoscopic light beam. BP was recorded as grade 0 when there is no expression, grade 1 when partial response is present (the center of pupil visible) and grade 2 when full response is present (the center of pupil is not visible). R Re es su ul lt ts s: : A total of 152 infants with a mean gestational age of 31.4±2.8 weeks and a mean birth weight of 1705.0±543.3 g. were enrolled in the study. Fourty-two (30.3%) grade 0, 70 (46.0%) grade 1 and 36 (23.7%) grade 2 responses were observed just after the insertion of the blepharostat. After illumination of the eye with the indirect ophthalmoscope, 31 (20.4%) grade 0, 60 (39.5%) grade 1 and 61 (40.1%) grade 2 responses were observed. No significant association was found between the gestational age and the frequency of BP just after insertion of the blepharostat. (p=0.856) However, there was a statistically significant difference of the expression frequency of BP between different age groups during illumination with the light of binocular indirect ophthalmoscope (p=0.008). C Co on nc cl lu us si io on n: : BP is commonly encountered in premature infants during retinopathy of prematurity screening examination. It should be taken into consideration during screening examination and laser treatment under topical anesthesia in order to prevent conjunctival injury and anterior segment ischemia.K Ke ey y W Wo or rd ds s: : Infant, premature; retinopathy of prematurity Ö ÖZ ZE ET T A Am ma aç ç: : Prematüre bebeklerde Bell fenomeni (BF) görülme sıklığını ve bu durumun prematüre retinopatisi tarama muayenesi sırasında neden olabileceği sonuçları tartışmak amaçlanmıştır. G Ge er re eç ç v ve e Y Yö ön nt te em ml le er r: : Prematüre retinopatisi tarama muayenesi için başvuran bebeklerde blefarosta takılmasını ve indirekt oftalmoskop ışığının göze tutulmasını takiben BF varlığı değerlendirildi. Yanıt alınamayan olgular evre 0, kısmi yanıt alınan olgular (pupil merkezi görülen) evre 1 ve tam yanıt alınan olgular (pupil merkezi görülemeyen) ise evre 2 olarak kaydedildi. B Bu ul lg gu ul la ar r: : Ortalama gestasyonel yaşı 31,4±2,8 hafta ve doğum ağırlığı 1705,0±543,3 g olan 152 bebek çalışma kapsamına alındı. Blefarosta takılmasını takiben 42 (%30,3) bebekte evre 0, 70 (%46,0) bebekte evre 1 ve 36 (%23,7) bebekte evre 2 yanıt izlendi. İndirekt oftalmoskop ışığı ile 31 (%20,4) bebekte evre 0, 60 (%39,5) bebekte evre 1 ve 61 (%40,1) bebekte evre 2 yanıt izlendi. Gestasyonel yaş ile blefarosta takılmasını takiben ortaya çıkan BF görülme sıklığı arasında ista...

show abstract

“…Anesthetic eye drops partially minimize the pain caused by eyelid speculum insertion, scleral indentation and the bright light of the binocular indirect ophthalmoscope during the eye exam for ROP (7,19,20). However, even with the use of anesthetic eye drops, pain is still present during the eye exam.…”

Section: Discussionmentioning

confidence: 99%

Oral glucose for pain relief during examination for retinopathy of prematurity: a masked randomized clinical trial

Costa¹,

Eckert²,

Fortes³

et al. 2013

Clinics

View full text Add to dashboard Cite

OBJECTIVE:Ophthalmologic examination for retinopathy of prematurity is a painful procedure. Pharmacological and non-pharmacological interventions have been proposed to reduce pain during eye examinations. This study aims to evaluate the analgesic effect of 25% glucose using a validated pain scale during the first eye examination for retinopathy of prematurity in preterm infants with birth weight ≤1,500 g and/or gestational age ≤32 weeks.METHODS:A masked, randomized clinical trial for one dose of 1 ml of oral 25% glucose solution 2 minutes before the first ophthalmologic examination for retinopathy of prematurity was conducted between March 2008 and April 2010. The results were compared to those of a control group that did not receive oral glucose solution. Pain was evaluated using a Neonatal Infant Pain Scale immediately before and immediately after the ophthalmologic examination in both groups. Clinicaltrials.gov: NCT00648687RESULTS:One hundred and twenty-four patients who were examined for the first time for retinopathy of prematurity were included. Seventy were included in the intervention group and 54 in the control group. The number of patients with pain immediately before the procedure was similar in both groups. The number of patients with pain after ophthalmologic examination was 15.7% in the intervention group and 68.5% in the control group (p<0.001).CONCLUSIONS:One ml of oral 25% glucose solution given 2 minutes before an ophthalmologic examination for retinopathy of prematurity was an effective measure for pain relief.

show abstract

Effect of topical anesthesia and age on pain scores during retinopathy of prematurity screening

Cited by 27 publications

References 25 publications

Pain relief for premature infants during ophthalmology assessment

Pain relief for premature infants during ophthalmology assessment

A Significant Challenge During Retinopathy of Prematurity Screening: Bell's Phenomenon

Oral glucose for pain relief during examination for retinopathy of prematurity: a masked randomized clinical trial

Contact Info

Product

Resources

About